Hypoplastic left heart syndrome (HLHS) is a continuum which can affect all left sided cardiac structures, from the mitral ... pulmonary venous congestion on chest x ray. These infants are generally ...
Background Although the prognostic implications of severe mitral regurgitation (MR) are well recognised, they are less clear ...
THE TCW trial has demonstrated that fractional flow reserve (FFR)-guided percutaneous PCI plus TAVI is superior to SAVR plus ...
Contraction of the foot and calf muscles initiates cephalad flow of blood and opens the one-way valves within the veins, which prevent retrograde flow after closing. Dysfunctional valves cause ...
Recent years have seen an enormous amount of experimental and clinical research into role of the pulmonary veins (PVs) in atrial fibrillation (AF). Advanced imaging techniques have confirmed the ...
Varicose veins are twisted, swollen veins that occur due to blood buildup. They may be blue or dark purple. Treatment is not always necessary but may involve remedies such as exercise and ...
The authors should be commended for their efforts to extend our mechanistic understanding of the interplay between DMR and RVD by evaluating the role of pulmonary hypertension ... Of the 73% of ...
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...
Baylor Pulmonary Medicine provides comprehensive, compassionate care to patients with common and complex medical conditions related to the lungs and breathing. Our pulmonary physicians work closely ...
surgery in patients with heart failure and secondary mitral regurgitation at 1 year. Patient selection is key for success of any surgical or percutaneous MV interventions. Generalization of these ...
In people with acid reflux, this muscle is weakened or dysfunctional, causing acid to flow into the esophagus. Many reflux symptoms take place after a meal. Eating smaller, more frequent meals ...
December 17, 2024—Flow Medical announced the closing of a $5 million seed funding round that will allow the company to accelerate the development and launch of its device for the treatment of ...